Select a State

Global health R&D delivers for Kansas

US government investment in global health R&D has delivered

$17.7 million
to Kansas research institutions
200+ new jobs
for Kansas

Neglected diseases in Kansas

Chikungunya cases
27
Dengue cases
23
HIV diagnoses
1,289
Malaria cases
61
Tuberculosis cases
396
West Nile cases
339
Zika cases
22

Kansas's top USG-funded global health R&D institutions

University of Kansas (including University of Kansas Medical Center)
$10.6 million
Kansas State University
$6.8 million
Children's Mercy Hospital Kansas
$340 thousand

Kansas industry in global health R&D

Bayer
Location(s):
Shawnee
Celgene
Location(s):
Overland Park
Orbis Biosciences
Location(s):
Lenexa

Kansas's top areas of global health R&D by USG funding

16.1%
HIV/AIDS
21.0%
Malaria
12.0%
Tuberculosis
21.7%
Diarrheal diseases
7.5%
Salmonella infections
14.0%
Neglected tropical diseases
Dengue
Kinetoplastids
7.7%
Other
Non-allocable

Global health R&D at work in Kansas

Researchers at the University of Kansas (KU) are working to develop a low-cost vaccine manufacturing platform for use in the world’s poorest nations. The researchers are collaborating with partners to standardize the development of new vaccines. Their goal is to create several vaccine candidates that cannot only be produced inexpensively but also remain stable to ensure their potency during storage, transport, and distribution. Affordable and reliable vaccines are a crucial element of disease prevention programs around the world. Delivered effectively, they can save lives and improve the health of entire populations. The KU team is also working on a needle-free vaccination method to be used with several currently available vaccines.

Footnotes